Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S
about
Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods studyReductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trialPandemic (H1N1) 2009 Surveillance in Marginalized Populations, Tijuana, Mexico.A Systematic Review of Published Respondent-Driven Sampling Surveys Collecting Behavioral and Biologic Data.Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico.Not sold here: limited access to legally available syringes at pharmacies in Tijuana, Mexico.The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response.High dead-space syringe use among people who inject drugs in Tijuana, MexicoBarriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities.Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities.Social and Structural Challenges to Drug Cessation Among Couples in Northern Mexico: Implications for Drug Treatment in Underserved CommunitiesHCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.Characteristics of female sex workers with US clients in two Mexico-US border cities.High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico.Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.Overlapping substance using high-risk groups and infectious diseases: how dynamic modelling can evaluate risk and target HIV prevention.Cross-border migration and initiation of others into drug injecting in Tijuana, Mexico.Institutional stakeholder perceptions of barriers to addiction treatment under Mexico's drug policy reform.Assessing police officers' attitudes and legal knowledge on behaviors that impact HIV transmission among people who inject drugs.Injection Drug Use Trajectories Among Migrant Populations: A Narrative Review.Cost of provision of opioid substitution therapy provision in Tijuana, Mexico.Prevalence of hepatitis C viral infection among injecting drug users in a Saudi Arabian hospital: A point cross sectional survey
P2860
Q24627413-CD2BB58D-E453-4872-B62F-FB765BDBBA21Q28533901-B66569B5-4CF4-40FA-9608-B46257F39C4CQ30392169-96007B00-AE6E-4B95-B75B-39CE37A619E4Q31060674-39AA20BC-484E-4BF6-A783-69279EAFC213Q34194106-4703DDEE-D32B-47BA-AF45-D127EB7FD088Q35063669-A68FAAA8-CC23-4D8F-8ADD-725014E9E30EQ35992661-376542DA-8D46-46FD-8602-A4FA13F36970Q36155511-ED3E3635-4687-4195-B7AB-3A70AAAE4349Q36376943-3E10F35F-B9A2-4F6D-803D-A4B83088E26CQ36404702-DBD9ED95-7991-411C-A0DF-CC953718218DQ36414723-B36E588C-9EF9-4934-97D2-35C550550F39Q36882069-F2FBBD69-5D35-4BBD-8727-F1794B620F4CQ37142229-00941105-F8B6-464F-BE2E-D638D1FF36D6Q37331957-3150893B-B324-407F-AA01-353397F67C16Q37347597-7673B1BE-AAB4-473C-89DA-AAB54356C026Q37620940-95580721-1973-4820-BC72-874108EB1652Q38690830-21DC6E34-CC2E-4D95-AE7B-F6C0BB726391Q40565281-B1322A36-5328-405D-9DB1-99642AB44B8FQ40716019-2C87CED4-5CB5-4E72-89AA-58989050A399Q45942905-0F6BDFA8-3BD5-4B3C-861A-960471DCBA05Q45978486-E1825ADC-508D-4D7C-AFD5-36FE28AA96E2Q46851771-73A17430-DF5A-4F27-A8E7-63E1150FA3E2Q47554713-AEFF0281-0C70-4CBB-8F2F-B9CC8D3C2B45Q55000232-616A34B3-3E85-40DA-97CB-9F5B763880BEQ56998834-55BB867E-E636-4F7D-8ECF-01C1823E14F8
P2860
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@ast
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@en
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@nl
type
label
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@ast
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@en
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@nl
prefLabel
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@ast
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@en
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@nl
P2093
P2860
P3181
P1476
Prevalence of hepatitis C viru ...... xican cities bordering the U.S
@en
P2093
Carlos J Conde-Glez
Carlos Magis-Rodríguez
Emily Faye White
Kimberly C Brouwer
Michelle Firestone-Cruz
Rebeca Ramos
Remedios Lozada
Richard S Garfein
Saida G Pérez
P2860
P304
P3181
P356
10.1590/S0036-36342007000300001
P407
P577
2007-01-01T00:00:00Z